Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Taiwan - Delayed Quote TWD

Tanvex BioPharma, Inc. (6541.TW)

59.60
-1.50
(-2.45%)
At close: 1:30:22 PM GMT+8
Currency in TWD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
34,678
34,678
61,411
22,404
5,406
Cost of Revenue
26,386
26,386
1,710
41,752
1,856
Gross Profit
8,292
8,292
59,701
-19,348
3,550
Operating Expense
1,365,033
1,365,033
2,160,451
1,586,169
1,602,734
Operating Income
-1,356,741
-1,356,741
-2,100,750
-1,605,517
-1,599,184
Net Non Operating Interest Income Expense
-23,158
-23,158
-28,344
-45,123
-43,078
Pretax Income
-1,381,203
-1,381,203
-2,136,673
-1,641,107
-1,543,189
Tax Provision
347
347
428
23
22
Net Income Common Stockholders
-1,381,550
-1,381,550
-2,137,101
-1,641,130
-1,543,211
Diluted NI Available to Com Stockholders
-1,381,550
-1,381,550
-2,137,101
-1,641,130
-1,543,211
Basic EPS
-10.94
-8.90
-16.58
-13.82
-13.79
Diluted EPS
-10.94
-8.90
-16.58
-13.82
-13.79
Basic Average Shares
148,928.94
155,230.34
128,896.32
118,732.47
111,845.23
Diluted Average Shares
148,928.94
155,230.34
128,896.32
118,732.47
111,845.23
Total Expenses
1,391,419
1,391,419
2,162,161
1,627,921
1,604,590
Net Income from Continuing & Discontinued Operation
-1,381,550
-1,381,550
-2,137,101
-1,641,130
-1,543,211
Normalized Income
-1,381,550
-1,381,550
-2,137,101
-1,641,130
-1,543,211
Interest Income
30,184
30,184
29,040
9,597
3,144
Interest Expense
53,342
53,342
57,384
54,720
46,222
Net Interest Income
-23,158
-23,158
-28,344
-45,123
-43,078
EBIT
-1,327,861
-1,327,861
-2,079,289
-1,586,387
-1,496,967
EBITDA
-1,038,821
-1,038,821
-1,754,456
-1,304,828
-1,253,385
Reconciled Cost of Revenue
26,386
26,386
1,710
41,752
1,856
Reconciled Depreciation
289,040
289,040
324,833
281,559
243,582
Net Income from Continuing Operation Net Minority Interest
-1,381,550
-1,381,550
-2,137,101
-1,641,130
-1,543,211
Normalized EBITDA
-1,038,821
-1,038,821
-1,754,456
-1,304,828
-1,253,385
Tax Rate for Calcs
0
0
0
0
0
12/31/2021 - 8/13/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

4147.TWO TaiMed Biologics Inc.
79.60
-1.24%
 
4174.TWO OBI Pharma, Inc.
42.20
-9.93%
 
4162.TWO PharmaEngine, Inc.
87.70
+0.34%
 
6589.TWO EirGenix Inc.
61.50
-0.81%
 
6492.TWO Senhwa Biosciences, Inc.
31.90
-0.78%
 
6550.TW Polaris Group
37.05
-1.85%
 
6919.TW CALIWAY BIOPHARMACEUTICALS CO L
608.00
-0.33%
 
4743.TWO Oneness Biotech Co., Ltd.
60.30
-1.63%
 
6838.TW Formosa Pharmaceuticals, Inc.
23.40
-1.27%
 
6535.TWO Lumosa Therapeutics Co., Ltd.
155.00
-2.21%